Nagoya, Japan

Eitaro Arakawa

This inventor holds 2 USPTO granted patents. Top assignee: Arax Co., Ltd.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eitaro Arakawa. Retrieved from https://idiyas.com/inventor/eitaro-arakawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Eitaro Arakawa: Innovator in Imidazoline Derivatives

Introduction

Eitaro Arakawa is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of chemistry, particularly in the development of imidazoline derivatives. With a total of 2 patents to his name, Arakawa's work is recognized for its potential applications in pharmaceuticals.

Latest Patents

Arakawa's latest patents include an imidazoline derivative and its possible tautomer, which is represented by a complex formula involving various substituents. This invention highlights the versatility of imidazoline compounds, which can be modified to enhance their therapeutic properties. Another patent focuses on an imidazole derivative, which also features intricate structural representations, showcasing his expertise in chemical synthesis and molecular design.

Career Highlights

Throughout his career, Eitaro Arakawa has been associated with Arax Co., Ltd., where he has contributed to innovative research and development projects. His work has not only advanced the understanding of imidazoline derivatives but has also paved the way for new pharmaceutical applications.

Collaborations

Arakawa has collaborated with esteemed colleagues such as Tetsuo Kato and Tsukasa Takamura. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of chemistry.

Conclusion

Eitaro Arakawa's contributions to the field of imidazoline derivatives exemplify the impact of innovative research in pharmaceuticals. His patents reflect a commitment to advancing chemical science and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…